share_log
Moomoo 24/7 ·  Apr 23 08:02
UNITY Biotechnology Inc: Phase 2B Aspire Study of Ubx1325 Is Being Upsized From 40 to 50 Patients to Increase Statistical Power
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment